Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms

Journal of Neuro-Oncology

Volumn 69, Issue 1-3, 2004, Pages 83-100

  McDermott, M W ^a,b,c   Berger, M S ^a   Kunwar, Sandeep ^c   Parsa, Andrew T ^c   Sneed, P K ^b   Larson, David A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Brachytheraphy; Malignant glioma; Radiosurgery

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT SELECTION; RADIOSURGERY; RECURRENT CANCER; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

BRACHYTHERAPY; BRAIN NEOPLASMS; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 19444383059     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000041873.42938.13     Document Type: Article

References (88)

1. Bernstein M, Gutin PH: Interstitial irradiation of brain tumors: a review. Neurosurgery 9: 741-750, 1981
2. Frazier C: The Effects of Rdium emanations upon brain tumors. Surg Gynecol Obstet 31: 236-239, 1920
3. Gutin PH, Prados MD, Phillips TL, et al.: External irradiation followed by an interstitial high activity iodine-125 implant 'boost' in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21: 601-606, 1991
4. McDermott MW, Sneed PK, Gutin PH: Interstitial brachytherapy for malignant brain tumors. Semin Surg Oncol 14: 79-87, 1998
5. Prados MD, Gutin PH, Phillips TL, et al.: Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys 24: 593-597, 1992
6. Scharfen CO, Sneed PK, Wara WM, et al.: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24: 583-591, 1992
7. Sneed PK, Lamborn KR, Larson DA, et al.: Demonstration of brachytherapy boost dose-response relationships in glioblastoma, multiforme. Int J Radiat Oncol Biol Phys 35: 37-44, 1996
8. Sneed PK, Stauffer PR, McDermott MW, et al.: Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40: 287-295, 1998
9. Florell RC, Macdonald DR, Irish WD, et al.: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76: 179-183, 1992
10. Laperriere NJ, Leung PM, McKenzie S, et al.: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41: 1005-1011, 1998
11. Selker RG, Shapiro WR, Burger P, et al.: The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine vs. surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51: 343-355; discussion 355-347, 2002
12. Larson DA, Suplica JM, Chang SM, et al.: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncology 6: in press
13. Chamberlain MC, Barba D, Kormanik P, et al.: Stereotactic radiosurgery for recurrent gliomas. Cancer 74: 1342-1347, 1994
14. Dunbar SF, Tarbell NJ, Kooy HM, et al.: Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 30: 531-539, 1994
15. Gannett D, Stea B, Lulu B, et al.: Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 33: 461-468, 1995
16. Hall WA, Djalilian HR, Sperduto PW, et al.: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13: 1642-1648, 1995
17. Larson DA, Gutin PH, Leibel SA, et al.: Stereotaxic irradiation of brain tumors. Cancer 65: 792-799, 1990
18. Larson DA, Gutin PH, McDermott M, et al.: Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 36: 1045-1053, 1996
19. Loeffler JS, Alexander E, 3rd, Shea WM, et al.: Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10: 1379-1385, 1992
20. Loeffler JS, Shrieve DC, Alexander E, 3rd: Radiosurgery for glioblastoma, multiforme: the importance of selection criteria. Int J Radiat Oncol Biol Phys 30: 731-733, 1994
21. Masciopinto JE, Levin AB, Mehta MP, et al.: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82: 530-535, 1995
22. McDermott MW, Sneed P, Chang S, et al.: Results of Radiosurgery for recurrent malignant gliomas, in Kondziolka D (ed): Radiosurgery 1995. Vol. 1, Karger, Basel, 1996, pp 102-112
23. Sarkaria JN, Mehta MP, Loeffler JS, et al.: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32: 931-941, 1995
24. Shaw E, Scott C, Souhami L, et al.: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34: 647-654, 1996
25. Shrieve DC, Alexander E, 3rd, Black PM, et al.: Treatment of patients with primary glioblastoma, multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90: 72-77, 1999
26. Shrieve DC, Alexander E, 3rd, Wen PY, et al.: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma, multiforme. Neurosurgery 36: 275-282; discussion 282-274, 1995
27. Souhami L, Scott C, Brachman D, et al.: Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93-05 Protocol. IJROBP 54 (Suppl): 94-95, 2002
28. Barker FG, 2nd, Prados MD, Chang SM, et al.: Radiation response and survival time in patients with glioblastoma, multiforme. J Neurosurg 84: 442-448, 1996
29. Graves EE, Nelson SJ, Vigneron DB, et al.: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46: 319-326; discussion 326-318, 2000
30. Larson DA, Prados M, Lamborn KR, et al.: Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 54: 1397-1404, 2002
31. Graves EE, Nelson SJ, Vigneron DB, et al.: Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 22: 613-624, 2001
32. Levivier M, Wikier D, Goldman S, et al.: Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. J Neurosurg 93 (Suppl 3): 233-238, 2000
33. Levivier M, Wikler D Jr, Massager N, et al.: The integration of metabolic imaging in stereotactic procedures including radiosurgery: a review. J Neurosurg 97: 542-550, 2002
34. Nelson SJ, Graves E, Pirzkall A, et al.: In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16: 464-476, 2002
35. Kondziolka D, Lunsford LD, Witt TC, et al.: The future of radiosurgery: radiobiology, technology, and applications. Surg Neurol 54: 406-414, 2000
36. McDermott MW, Gutin PH, Berger MS, et al.: Interstitial and intracavitary irradiation of brain tumors. In: Winn HR (ed) Neurological Surgery. Vol. 4, Elsevier, Philadelphia, 2003, pp 4095-4109
37. Krishnaswamy V: Dose distribution around an 125I seed source in tissue. Radiology 126: 489-491, 1978
38. Dempsey JF, Williams JA, Stubbs JB, et al.: Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins. Int J Radiat Oncol Biol Phys 42: 421-429, 1998
39. Tatter SB, Shaw EG, Rosenblum ML, et al.: An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J Neurosurg 99: 297-303, 2003
40. Gutin PH, Bernstein M: Stereotactic interstitial brachytherapy for malignant brain tumors. Prog Exp Tumor Res 28: 166-182, 1984
41. Armour EP, Wang ZH, Corry PM, et al.: Sensitization of rat 9L gliosarcoma cells to low dose rate irradiation by long duration 41 degrees C hyperthermia. Cancer Res 51: 3088-3095, 1991
42. Fowler JF: Why shorter half-times of repair lead to greater damage in pulsed brachytherapy. Int J Radiat Oncol Biol Phys 26: 353-356, 1993
43. Fu KK, Phillips TL, Kane LL et al.: Tumor and normal tissue response to irradiation in vivo: variation with decreasing dose rates. Radiology 114: 709-716, 1975
44. Hall EJ: The promise of low dose rate: has it been realized? Int J Radiat Oncol Biol Phys 4: 749-750, 1978
45. Hall EJ: Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. Br J Radiol 45: 81-97, 1972
46. Ling CC, Spiro IJ, Mitchell J, et al.: The variation of OER with dose rate. Int J Radiat Oncol Biol Phys 11: 1367-1373, 1985
47. Schultz CJ, Geard CR: Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 19: 1397-1403, 1990
48. Arbit E, Shapiro JR, Fiola M, et al.: The significance of morphologically viable glioma cells found at the time of operation after interstitial brachytherapy. Neurosurgery 32: 105-110, 1993
49. Ling CC, Chui CS: Stereotactic treatment of brain tumors with radioactive implants or external photon beams: radiobiophysical aspects. Radiother Oncol 26: 11-18, 1993
50. Knox SJ, Sutherland W, Goris ML: Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters. Radiat Res 135: 24-31, 1993
51. Backlund EO: Colloidal radioisotopes as part of a multimodality treatment of craniopharyngiomas. J Neurosurg Sci 33: 95-97, 1989
52. Backlund EO, Axelsson B, Bergstrand CG, et al.: Treatment of craniopharyngiomas - the stereotactic approach in a ten to twenty-three years' perspective. I. Surgical, radiological and ophthalmological aspects. Acta Neurochir (Wien) 99: 11-19, 1989
53. Coffey RJ, Lunsford LD: The role of stereotactic techniques in the management of craniopharyngiomas. Neurosurg Clin N Am 1: 161-172, 1990
54. Fig LM, Shapiro B, Taren J: Distribution of [32P]-chromic phosphate colloid in cystic brain tumors. Stereotact Funct Neurosurg 59: 166-168, 1992
55. Adler JR Jr, Chang SD, Murphy MJ, et al.: The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 69: 124-128, 1997
56. Loeffler JS, Siddon RL, Wen PY, et al.: Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiother Oncol 17: 311-321, 1990
57. Schultz CJ, Gillin M, Mueller WM: Modified linear accelerator radiosurgery: principles and techniques. In: Germano IM (ed) Linac and Gamma Knife Radiosurgery. American Association of Neurological Surgeons, Park Ridge, 2000, pp 19-30
58. Loeffler J, Singer RJ, Chapman PH, et al.: Proton-beam radiation therapy. In: Germano IM (ed) Linac and Gamma Knife Radiosurgery. American Association of Neurological Surgeons, Park Ridge, 2000, pp 71-74
59. Yamamoto M: Gamma Knife radiosurgery: technology, applications and future directions. Neurosurg Clin N Am 10: 181-202, 1999
60. Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47: 291-298, 2000
61. Larson DA, Flickinger JC, Loeffler JS: The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys 25: 557-561, 1993
62. Curran WJ Jr, Scott CB, Weinstein AS, et al.: Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11: 857-862, 1993
63. Haines SJ: Moving targets and ghosts of the past: outcome measurement in brain tumour therapy. J Clin Neurosci 9: 109-112, 2002
64. Videtic GM, Gaspar LE, Zamorano L, et al.: Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 45: 687-692, 1999
65. Sneed PK, Prados MD, McDermott MW, et al.: Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36: 898-903; discussion 903-894, 1995
66. Sneed PK, Larson DA, Gutin PH: Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol 21: 186-197, 1994
67. Bampoe J, Laperriere N, Pintilie M, et al.: Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg 93: 917-926, 2000
68. Gaspar LE, Zamorano LJ, Shamsa F, et al.: Permanent 125iodine implants for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 43: 977-982, 1999
69. Halligan JB, Stelzer KJ, Rostomily RC, et al.: Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 35: 541-547, 1996
70. Patel S, Breneman JC, Warnick RE, et al.: Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma, multiforme. Neurosurgery 46: 1123-1128; discussion 1128-1130, 2000
71. Videtic GM, Gaspar LE, Zamorano L, et al.: Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 51: 963-968, 2001
72. Buatti JM, Friedman WA, Bova FJ, et al.: Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 32: 205-210, 1995
73. Mehta MP, Masciopinto J, Rozental J, et al.: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30: 541-549, 1994
74. Kondziolka D, Flickinger JC, Bissonette DJ, et al.: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41: 776-783; discussion 783-775, 1997
75. Nwokedi EC, DiBiase SJ, Jabbour S, et al.: Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50: 41-46; discussion 46-47, 2002
76. Boethius J, Ulfarsson E, Rahn T, et al.: Gamma knife radiosurgery for pilocytic astrocytomas. J Neurosurg 97: 677-680, 2002
77. Hadjipanayis CG, Kondziolka D, Gardner P, et al.: Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg 97: 56-64, 2002
78. Bernstein M, Laperriere N, Glen J, et al.: Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 30: 1213-1217, 1994
79. Chamberlain MC, Barba D, Kormanik P, et al.: Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Neurol 52: 162-167, 1995
80. Coffey RJ, Friedman WA: Interstitial brachytherapy of malignant brain tumors using computed tomography-guided stereotaxis and available imaging software: technical report. Neurosurgery 20: 4-7, 1987
81. Leibel SA, Gutin PH, Wara WM, et al.: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17: 1129-1139, 1989
82. Loeffler JS, Alexander E, 3rd, Hochberg FH, et al.: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19: 1455-1462, 1990
83. Loeffler JS, Alexander E, 3rd, Wen PY, et al.: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918-1921, 1990
84. McDermott MW, Gutin PH, Larson DA, et al.: Interstitial brachytherapy. Neurosurg Clin N Am 1: 801-824, 1990
85. Sneed PK, Gutin PH, Prados MD, et al.: Brachytherapy of brain tumors. Stereotact Funct Neurosurg 59: 157-165, 1992
86. Sneed PK, Russo C, Scharfen CO, et al.: Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg 24: 314-322, 1996
87. Simon JM, Cornu P, Boisserie G, et al.: Brachytherapy of glioblastoma, recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys 53: 67-74, 2002
88. Sarkar A, Pollock BE, Brown PD, et al.: Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomas. J Neurosurg 97: 653-656, 2002